The HIV Vaccine Trials Network, in collaboration with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, is investing in a young generation of HIV prevention researchers by providing medical students from communities that are underrepresented in medicine in the US with opportunities to conduct independent research while receiving mentoring, project and salary funding, training, and professional development opportunities.
The complete Request for Applications can be found at https://www.hvtn.org/ramp on October 1, 2024.
Grant recipients will be mentored by HVTN-affiliated investigators while conducting research projects in areas of basic, clinical, behavioral, and social science. Projects will be:
Short-Term Projects: 8-10 weeks
- Timed with a summer break or fourth-year research elective
- Travel to an HIV Vaccine Clinical Research Site in the US or abroad
- Attend and present at an HVTN Conference
- Maximum award of $20,000
Project Options
During the application process, scholars will have the opportunity to rank all of the research projects according to their interests. Projects for the 2025-2026 cycle will be posted to the following link on October 1, 2024: https://www.hvtn.org/ramp.
To see the projects of our current and former scholars, check out their profiles.
Eligibility Criteria
- Medical students who self-identify as being from communities that are underrepresented in medicine in the US
- Attending US MD, DO programs, or international medical schools that are US certification eligible (ECFMG)
- In good academic standing
- US citizen or US permanent resident or DACA status
- Interested in pursuing a future career in HIV research
Application Materials
To apply, visit http://www.hvtn.org/ramp. The Request For Applications (RFA) and application materials will be available on October 1, 2024. Carefully read the Request for Applications before applying. Applications are due online by 5:00 PM PT on Monday, December 2, 2024.
For More Information
All correspondence concerning the program should be addressed to:
Linda Oseso, MPH
RAMP Program Manager
HIV Vaccine Trials Network
Fred Hutchinson Cancer Center
1100 Fairview Ave. N., Mail Stop M2-B500
Seattle, WA 98109
206-667-2175
loseso@fredhutch.org |